XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Oct 31, 2024 | (FY)Oct 31, 2023 | (FY)Oct 31, 2022 | (FY)Oct 31, 2021 | (FY)Oct 31, 2020 | (FY)Oct 31, 2019 | (FY)Oct 31, 2018 | (FY)Oct 31, 2017 | |
---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||
Cash flow from continuing operating activities | ||||||||
Net income from continuing operations | -0.65%37.24M | 143.69%37.49M | -1,714.36%-85.8M | 119.48%5.32M | -142.94%-27.28M | 209.29%63.53M | -292.37%-58.13M | --30.22M |
Other non cashItems | -347.40%-16.34M | -152.56%-3.65M | -5.24%-1.45M | 68.94%-1.37M | 16.72%-4.42M | 21.84%-5.31M | -78.65%-6.8M | ---3.8M |
Change in working capital | 63.16%-5.71M | -5.59%-15.5M | -308.58%-14.68M | -85.97%7.04M | 334.20%50.14M | -200.84%-21.41M | 215.03%21.23M | ---18.46M |
-Change in receivables | -85.97%55K | -69.47%392K | 601.56%1.28M | -119.05%-256K | -60.31%1.34M | 117.89%3.39M | 37.40%1.55M | --1.13M |
-Change in other current assets | 54.44%-7.46M | 5.17%-16.38M | -303.52%-17.28M | -82.17%8.49M | 298.61%47.6M | -205.88%-23.97M | 195.68%22.63M | ---23.66M |
-Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued operating activities | ||||||||
Operating cash flow | -85.30%10.17M | 12.16%69.21M | 51.81%61.71M | -41.72%40.65M | -37.49%69.75M | 49.64%111.58M | -6.45%74.57M | --79.71M |
Investing cash flow | ||||||||
Cash flow from continuing investing activities | ||||||||
Cash from discontinued investing activities | ||||||||
Financing cash flow | ||||||||
Cash flow from continuing financing activities | ||||||||
Net issuance payments of debt | 157.47%25M | -10.70%-43.5M | -81.13%-39.3M | 32.26%-21.7M | 54.08%-32.03M | -132.49%-69.75M | 14.29%-30M | ---35M |
Net commonstock issuance | -12.73%-3.78M | -485.51%-3.36M | ---573K | ---- | ---- | 59.94%-2.11M | ---5.27M | ---- |
Cash dividends paid | -38.94%-29.12M | 2.31%-20.96M | 16.76%-21.46M | 15.22%-25.78M | 22.09%-30.4M | 2.44%-39.02M | 9.72%-40M | ---44.3M |
Net other financing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||||||
Financing cash flow | 88.34%-7.91M | -10.58%-67.82M | -29.18%-61.33M | 23.96%-47.47M | 43.69%-62.43M | -47.31%-110.88M | 5.09%-75.27M | ---79.3M |
Net cash flow | ||||||||
Beginning cash position | 80.58%3.12M | 20.73%1.73M | -82.64%1.43M | 776.43%8.26M | 234.00%942K | ---703K | --0 | ---402K |
Current changes in cash | 62.70%2.27M | 263.97%1.39M | 105.61%383K | -193.29%-6.82M | 940.40%7.31M | 200.00%703K | -274.88%-703K | --402K |
End cash position | 72.60%5.39M | 72.03%3.12M | 26.73%1.82M | -82.64%1.43M | --8.26M | --0 | ---703K | --0 |
Free cash flow | -85.30%10.17M | 12.16%69.21M | 51.81%61.71M | -41.72%40.65M | -37.49%69.75M | 49.64%111.58M | -6.45%74.57M | --79.71M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |